Literature DB >> 23143080

Open surgery is dead, long live endourology: is it always true? (Re: comparative analyses of percutaneous nephrolithotomy versus open surgery in pediatric urinary stone disease).

Berkan Resorlu, Murat Tolga Gulpinar, Alpaslan Akbas.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23143080     DOI： 10.1007/s00383-012-3218-z

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN： 0179-0358            Impact factor:   1.827


× No keyword cloud information.
  6 in total

1.  Retrograde intrarenal surgery in infants and preschool-age children.

Authors:  Ali Unsal; Berkan Resorlu
Journal:  J Pediatr Surg       Date:  2011-11       Impact factor: 2.545

Review 2.  Complications in percutaneous nephrolithotomy.

Authors:  Maurice Stephan Michel; Lutz Trojan; Jens Jochen Rassweiler
Journal:  Eur Urol       Date:  2006-10-25       Impact factor: 20.096

3.  Percutaneous nephrolithotomy in children before school age: experience of a Pakistani centre.

Authors:  Mamun Mahmud; Zafar Zaidi
Journal:  BJU Int       Date:  2004-12       Impact factor: 5.588

4.  Comparative analyses of percutaneous nephrolithotomy versus open surgery in pediatric urinary stone disease.

Authors:  Omer Bayrak; Ilker Seckiner; Sakip Erturhan; Ibrahim Duzgun; Faruk Yagci
Journal:  Pediatr Surg Int       Date:  2012-07-18       Impact factor: 1.827

5.  Safety and efficacy of percutaneous nephrolithotomy in infants, preschool age, and older children with different sizes of instruments.

Authors:  Ali Unsal; Berkan Resorlu; Cengiz Kara; Omer Faruk Bozkurt; Ekrem Ozyuvali
Journal:  Urology       Date:  2010-07       Impact factor: 2.649

6.  Comparison of retrograde intrarenal surgery and mini-percutaneous nephrolithotomy in children with moderate-size kidney stones: results of multi-institutional analysis.

Authors:  Berkan Resorlu; Ali Unsal; Abdulkadir Tepeler; Gokhan Atis; Zafer Tokatli; Derya Oztuna; Abdullah Armagan; Cenk Gurbuz; Turhan Caskurlu; Remzi Saglam
Journal:  Urology       Date:  2012-06-05       Impact factor: 2.649
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.